Introduction
Time constraints are limiting the amount of time that physicians and consumers spend to search for information, as well as the amount of time that pharmaceutical companies have to access physicians. As a result, the importance of pharmaceutical websites is growing. This tool looks at the success factors for the physician- and consumer-targeted websites of the top 20 pharmaceutical companies.
Reasons to Purchase
- Assess and compare the value of the top 20 pharmaceutical companies’ Web presence across a number of criteria
- Identify which tools are being used to encourage US and European physicians to revisit a website and to drive new users to the site
- Compare the websites of products in the same class to see what gives the leaders a competitive edge
Other selected research from the 'Europe' category:
Pharma Market Authorization Strategies: A guide to launching drugs quickly and efficiently in Europe
This report is a comprehensive source of market analysis of the most valuable therapy area within the global pharmaceutical market; Valued at an estimated $73.7bn in 2002, the global market for cardiovascular drugs grew by a moderate 2.5% over 2001 levels Learn More
Pharmaceuticals in Europe
Pharmaceuticals in Europe industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry. Learn More